Department of Hepato-Gastroenterology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Department of Pathology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
United European Gastroenterol J. 2019 Apr;7(3):369-376. doi: 10.1177/2050640618817215. Epub 2019 Jan 12.
The feasibility and outcome of endoscopic resection in ampullary tumors with intraductal growth remains unclear.
To assess the safety, feasibility and outcomes of these patients treated by thermal ablation.
Retrospective observational study. All consecutive patients who underwent an endoscopic snare papillectomy with a 6-month minimum follow-up were included. Ablation was performed with cystotomes and soft/forced coagulation. Successful endoscopic treatment was defined as no adenomatous residual tissue or recurrence observed at follow-up.
Of 86 patients presenting with an ampullary tumor, 73 (58 ± 14 years old, 49% men, 34% familial adenomatous polyposis) (median tumor size: 20 mm, range: 8-80) were included. En bloc and curative resection rates were achieved in 46.6% and 83.6%, respectively.Intraductal ingrowth was seen in 18 (24.7%) patients and histologically confirmed in 12 (16.4%). Intraductal ablation achieved a 100% success rate, with a 20-month median follow-up. Most of these patients had malignant forms ( = 8, 66.7%), with a higher adenocarcinoma rate (33.3% versus 3.3%, = 0.001) compared to extraductal tumors.Overall, there was a 20.5% complication rate with no significant differences between both groups ( = 0.676).
Intraductal ablation achieves a high therapeutic success rate in ampullary tumors with ≤20 mm ductal extension, even in malignant forms or biliary and pancreatic involvement. The technique is feasible, cheap and safe and may avoid major surgery.
内镜下切除具有管内生长的壶腹肿瘤的可行性和结果尚不清楚。
评估这些患者经热消融治疗的安全性、可行性和结果。
回顾性观察性研究。所有连续接受内镜套扎乳头切除术且随访时间至少为 6 个月的患者均纳入研究。采用膀胱切开刀和软/强制凝块进行消融。成功的内镜治疗定义为在随访中未观察到腺瘤性残留组织或复发。
在 86 例壶腹肿瘤患者中,73 例(58 ± 14 岁,男性占 49%,家族性腺瘤性息肉病占 34%)(中位肿瘤大小:20mm,范围:8-80mm)纳入研究。整块和根治性切除率分别为 46.6%和 83.6%。18 例(24.7%)患者存在管内浸润,其中 12 例(16.4%)经组织学证实。在 20 个月的中位随访中,管内消融的成功率为 100%。这些患者大多为恶性肿瘤(8 例,66.7%),腺癌发生率高于管外肿瘤(33.3%比 3.3%, = 0.001)。总的来说,两组并发症发生率均为 20.5%,差异无统计学意义( = 0.676)。
对于胆管直径扩展≤20mm 的壶腹肿瘤,即使是恶性肿瘤或胆管和胰腺受累,管内消融也能达到较高的治疗成功率。该技术可行、廉价且安全,可避免大手术。